by SEQENS North America | Oct 5, 2021 | Blog, CDMO, collaboration, SEQENS
A number of years ago, Seqens, now a part of Seqens CDMO North America, endowed a summer research internship at Clark University, an academic institution an hour outside of Boston. It was done at the behest of Mark Turnbull, PhD, a chemistry professor in the...
by SEQENS North America | Sep 28, 2021 | API Manufacturing, Blog, CDMO, injectables
Intravenous or intramuscular injection of drugs is becoming a fast and effective route to administration of life-saving treatments. Injectable drugs do not involve absorption in the digestive tract, which allows the medication to be absorbed more quickly. The three...
by SEQENS North America | Sep 14, 2021 | API Manufacturing, Blog, CDMO, Continuous Manufacturing, Managed Services Agreement, SEQENS, Speciality Chemicals
I was privileged to work at Sanofi for 21 years, where I had the opportunity to be deeply involved in both technical and business aspects of innovative product development, partnership management, as well as the Contract Development & Manufacturing Organization...
by SEQENS North America | Jun 30, 2021 | Blog, Research and Development, risk management
In drug development, there is an inherent amount of uncertainty, which translates into risk. Uncertainty is caused by the organic nature of raw materials, making it impossible to predict how an Active Pharmaceutical Ingredient (API) will behave, how much yield...
by SEQENS North America | Jun 22, 2021 | API Manufacturing, Blog, Research and Development, Scale-up, Technology Transfer
It seems simple enough: a CDMO is chosen to manufacture an API, takes the chemistry right into the manufacturing suite, adjusts the equipment and begins to produce the drug substance in a process no more complicated than making children’s plastic beach shovels. ...
